Open original FDA record ↗Recall record
- FDA identifier
- Z-2154-2011
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc.
- FDA classification date
- May 9, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Results may be falsely depressed up to 0.4 mg/dL or falsely elevated up to 0.6 mg/dL across the assay range.
Source facts
- Action
- Siemens sent an Urgent Field Safety Notice letter dated June 2010 to all Dimension Vista(R) ECREA customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were advised to: Discontinue use of ECREA method and transition to the Dimension(R) Jaffe creatinine (CREA) method. To notify anyone to whom they may have distributed the product. Complete and return the Effectiveness Check Questionnaire attached to the letter by fax to (302) 631-8467. For questions regarding this recall call (302) 631-6299.
- Initiated
- 2010-06-10
- Root cause
- Device Design
- Terminated
- 2013-12-19
- Distribution
- Nationwide Distribution - including AL, AZ, CA, CO, DE, FL, GA, ID, IL, IA, MD, MA, MI, MT, NH, NJ, NY, NC, OH, OR, PA, SC, TX, VA, WA, and WI.
- Recall number
- Z-2154-2011
- Recall status
- Terminated
- CDRH record ID
- 99240
- FDA classified
- 2011-05-09
- Recall event number
- 58379